Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China · Delayed Price · Currency is CNY 29.48
+0.42 (1.45%)
At close: Oct 23, 2026
SHA:603014 Market Cap
SHA:603014 has a market cap or net worth of 12.32 billion as of October 23, 2026. It is the 6,938th most valuable company in the world and the 1,300th biggest in China. Its market cap has decreased by 23.65% in one year.
Market Cap
12.32B
Enterprise Value
9.66B
Revenue
3.76B
Global Rank
Country Rank
#1,300 China
PE Ratio
24.84
ChartMarket Cap Chart
Since May 19, 2025, SHA:603014's market cap has decreased from 17.04B to 12.32B, a decrease of -27.71%. That is a compound annual growth rate of -20.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 12.32B | -25.61% |
| Dec 31, 2025 | 16.56B | -2.82% |
| May 19, 2025 | 17.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Double Medical Technology | 15.89B |
| MeHow Innovative | 12.63B |
| Jafron Biomedical | 11.68B |
| Insight Lifetech | 11.58B |
| Cofoe Medical Technology | 11.44B |
| Qingdao Haier Biomedical Co.,Ltd | 10.23B |
| Shanghai MicroPort Endovascular MedTech | 10.15B |
| Beijing Balance Medical Technology | 9.83B |